The invention discloses application of CTSH serving as a diagnosis and treatment marker of multiple myeloma. Accordingly, the CTSH can be used for developing products for diagnosing the multiple myeloma and drugs for treating the multiple myeloma. According to research results, a theoretical basis is provided for clinicians to establish individualized treatment plans, and a novel drug target can be provided for development of multiple myeloma drugs.